ING announced today that Steven van Rijswijk, currently member of the Executive Board and chief risk officer of ING, will succeed Ralph Hamers as CEO and chairman of the Executive Board. The Supervisory Board has appointed Steven van Rijswijk effective 1 July 2020. As announced earlier, Ralph Hamers will leave ING to join UBS, where he will become CEO later in the year. Hans Wijers, chairman of the Supervisory Board of ING said: “We are very pleased to appoint Steven,...

Read more

On 10 June 2020, the German government published its long-awaited national hydrogen agenda. Earlier, the Dutch government also published its own hydrogen agenda and the policy overlap is clear: as far as the Dutch and the Germans are concerned, hydrogen will play an important role in the future energy supply of Europe. The Dutch government published its hydrogen agenda on 30 March 2020. In the agenda, particular attention is paid to the creation of potential transportation hubs function which the Netherlands could...

Read more

June 17, 2020 | New York, NY Tradewind Finance is pleased to announce that Emilio Estevez has joined the company as Vice President of Sales based out of their New York office. Emilio will leverage his experiences building client relationships and structuring deals in the trade finance space to help drive Tradewind’s factoring and supply chain financing business and expand their international client base, including in Latin America where he concentrated his business development efforts previously. Emilio will be reporting...

Read more

June 17, 2020 | A message from Sascha Leske, Head of NY Office of Noerr In light of the continuing reopening in Germany and across Europe, my Noerr colleagues and I would like to highlight a few important measures that the respective governments are implementing. Key elements that may be of particular interest include the specific measures aimed at enhancing investments in core industry sectors; and the financial support that subsidiaries of U.S. companies in Germany and across Europe may...

Read more

June 12, 2020 | IRS Notice 2020-39 provides relief from certain deadlines under Section 1400Z-2 of the Internal Revenue Code of 1986 and the U.S. Department of the Treasury regulations thereunder (the Opportunity Zone Rules). Delay caused by the impact of the COVID-19 pandemic have made achieving these deadlines within the time expected difficult or impossible. Accordingly, the IRS has acted to assist taxpayers adversely impacted by the COVID-19 crisis by tolling or extending certain important Opportunity Zone deadlines. ...

Read more

June 16, 2020 | The new “abnormal;” that’s what we can expect. Something distinctly different in our office experience. So, if you’re wondering how this will all play out when you return to the office, here’s what you may find: First, you’ll need to find a comfortable pathway to the office, which means you’ll need to grapple with the subway/bus/train/bike commute to work. When you arrive at your building, you’ll likely find your office lobby converted to what looks like a...

Read more

New safety standards and contactless stays across all our hotels. As the world opens up again, you’ll be looking for business travel. Luckily for you, mobile citizen – we built a pandemic-proof hotel. We could be smug, say we planned it. But the truth is, we accidentally got it just right. Our cleaning routine was already world-class – now, it’s beyond amazing. And while the world stopped, we upgraded – introducing a new contactless experience powered by our new app....

Read more

June 15, 2020 | CILcare, world leading CRO entirely specialized in the field of hearing disorders, announces a strategic partnership with the start-up Vertidiag, a company specialized in balance disorders. By combining their unique know-how, CILcare and Vertidiag can propose a complete service offering to identify and develop therapeutic solutions for people suffering from ear diseases including Hearing Loss, Tinnitus, Otitis and Vertigo. CILcare has developed its foundations on unique expertise in testing the efficacy and safety of drugs, gene &...

Read more